0000950170-24-029953 Sample Contracts

ALIGOS THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • March 12th, 2024 • Aligos Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Change in Control and Severance Agreement
• Filed
  March 12th, 2024
• Company
  Aligos Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Matthew McClure (“Executive”) and Aligos Therapeutics, Inc. (the “Company”), effective as of December 1, 2020 (the “Effective Date”).

SEPARATION AND GENERAL RELEASE AGREEMENT

Separation and General Release Agreement • March 12th, 2024 • Aligos Therapeutics, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  Separation and General Release Agreement
• Filed
  March 12th, 2024
• Company
  Aligos Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)

THIS SEPARATION AND GENERAL RELEASE AGREEMENT (this “Agreement”) is made and entered into as of the Effective Date, defined in Section 6(e) below, by and between, Leonid Beigelman, Ph.D., an individual (the “Employee”), and Aligos Therapeutics, Inc., a Delaware Corporation (the “Company”) (collectively the “Parties,” and each a “Party”).